VANGUARD GROUP INC - ADIAL PHARMACEUTICALS INC ownership

ADIAL PHARMACEUTICALS INC's ticker is ADIL and the CUSIP is 00688A106. A total of 9 filers reported holding ADIAL PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of ADIAL PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$42,339
-40.5%
203,3580.0%0.00%
Q1 2023$71,175
-30.9%
203,358
-57.5%
0.00%
Q4 2022$102,958
-52.3%
478,875
-22.4%
0.00%
Q3 2022$216,000
-72.7%
616,855
+4.4%
0.00%
Q2 2022$792,000
-33.3%
590,8520.0%0.00%
Q1 2022$1,187,000
-25.6%
590,8520.0%0.00%
Q4 2021$1,595,000
-37.5%
590,852
-0.6%
0.00%
Q3 2021$2,550,000
+70.9%
594,443
+1.6%
0.00%
Q2 2021$1,492,000
+186.9%
585,035
+172.4%
0.00%
Q1 2021$520,000
+55.2%
214,797
+9.1%
0.00%
Q4 2020$335,000
-23.7%
196,7970.0%0.00%
Q3 2020$439,000
+11.7%
196,797
-30.4%
0.00%
Q2 2020$393,000
+6.8%
282,9090.0%0.00%
Q1 2020$368,000
-46.0%
282,9090.0%0.00%
Q4 2019$682,000
+60.8%
282,9090.0%0.00%
Q3 2019$424,000
-14.2%
282,909
-3.7%
0.00%
Q2 2019$494,000
-52.6%
293,908
-3.2%
0.00%
Q1 2019$1,042,000
+421.0%
303,708
+679.1%
0.00%
Q4 2018$200,00038,9820.00%
Other shareholders
ADIAL PHARMACEUTICALS INC shareholders Q4 2018
NameSharesValueWeighting ↓
VANGUARD GROUP INC 38,982$200,0000.00%
LADENBURG THALMANN FINANCIAL SERVICES INC. 802$5,0000.00%
UBS Group AG 2,723$14,0000.00%
TWO SIGMA INVESTMENTS, LP 11,775$60,0000.00%
WELLS FARGO & COMPANY/MN 250$1,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 27,162$138,0000.00%
MORGAN STANLEY 545$3,0000.00%
BlackRock Inc. 205,684$1,053,0000.00%
View complete list of ADIAL PHARMACEUTICALS INC shareholders